Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections

Research output: Contribution to journalArticle

Abstract

The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed.

Original languageEnglish (US)
Pages (from-to)283-288
Number of pages6
JournalDrugs of the Future
Volume43
Issue number4
DOIs
StatePublished - Jan 1 2018

Fingerprint

HIV
Pharmaceutical Preparations
Monoclonal Antibodies
Research

Keywords

  • ALT-803
  • Lefitolimod
  • MB66
  • Novel formulations
  • Pembrolizumab
  • VRC07-523LS

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{fc74e84196a34091b93acad46c88933a,
title = "Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections",
abstract = "The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed.",
keywords = "ALT-803, Lefitolimod, MB66, Novel formulations, Pembrolizumab, VRC07-523LS",
author = "Stacey Rizza and R. Bhatia and Zelalem Temesgen",
year = "2018",
month = "1",
day = "1",
doi = "10.1358/dof.2018.043.04.2809259",
language = "English (US)",
volume = "43",
pages = "283--288",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "4",

}

TY - JOUR

T1 - Novel HIV drugs and drug delivery strategies. A report from the 2018 Conference on Retroviruses and Opportunistic Infections

AU - Rizza, Stacey

AU - Bhatia, R.

AU - Temesgen, Zelalem

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed.

AB - The 2018 Conference on Retroviruses and Opportunistic Infections (CROI 2018) was held from March 4 to March 7, 2018, in Boston, Massachusetts. Important research on all aspects of HIV was presented and discussed. This report focuses on new drugs that were presented at CROI 2018, including drugs for the reversal of latency and monoclonal antibodies. Presentations on new drug delivery strategies, such as nanoformulations, intradermal implants and topical formulations are also reviewed.

KW - ALT-803

KW - Lefitolimod

KW - MB66

KW - Novel formulations

KW - Pembrolizumab

KW - VRC07-523LS

UR - http://www.scopus.com/inward/record.url?scp=85048021205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048021205&partnerID=8YFLogxK

U2 - 10.1358/dof.2018.043.04.2809259

DO - 10.1358/dof.2018.043.04.2809259

M3 - Article

VL - 43

SP - 283

EP - 288

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 4

ER -